Among them, Nelarabine and Fludarabine can have certain curative effect on leukemia, suggesting that PTPN2 is closely correlated to drug resistance in patients with hematologic tumors. The gene discussed is PTPN2; the disease is hematopoietic and lymphoid cell neoplasm.